Exact syringe draw for every titration step. How to reconstitute a 5 mg or 10 mg vial, which BAC water volume to use, and how to read the unit lines correctly on a 100-unit insulin syringe.
| Titration Step | Dose | 10 mg/2 mL vial | Draw (units) |
|---|---|---|---|
| Weeks 1-4 | 2.5 mg | 0.5 mL | 50 units |
| Weeks 5-8 | 5 mg | 1.0 mL | 100 units |
| Weeks 9-12 | 7.5 mg | 1.5 mL | 150 units* |
| Weeks 13-16 | 10 mg | 2.0 mL | 200 units* |
| Weeks 17-20 | 12.5 mg | 2.5 mL | 250 units* |
| Maintenance | 15 mg | 3.0 mL | 300 units* |
* Draws over 100 units require more than one insulin syringe. Use the ASCEND calculator to confirm exact draws for any vial size and BAC water combination.
Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist (MW ~4,813 Da) supplied as a lyophilized powder. Before dosing, it must be reconstituted with bacteriostatic water. The BAC water volume you choose sets the concentration and determines every draw volume for the life of that vial.
For a 10 mg vial, 2 mL of BAC water gives 5 mg/mL. This is the most practical ratio: the 2.5 mg starting dose draws to exactly the 50-unit line, and every subsequent titration step scales cleanly. A 5 mg vial with 1 mL BAC water gives the same 5 mg/mL concentration and the same draw table.
The standard titration is 2.5 mg weekly for four weeks, then a 2.5 mg increase every four weeks up to a maximum of 15 mg. This schedule mirrors the SURPASS and SURMOUNT clinical trial protocols. The 4-week hold at each dose level is not arbitrary: GLP-1 receptor agonists slow gastric emptying, and the GI adaptation window at each new dose level takes approximately 3-4 weeks to stabilize.
Escalating faster than every 4 weeks significantly increases nausea and vomiting rates. In the SURMOUNT-1 trial, participants who tolerated the 2.5 mg step for the full 4 weeks before escalating had substantially lower dropout rates due to GI adverse effects. If GI symptoms persist at a given dose level, remaining at that dose for an additional 4 weeks before the next increase is standard practice.
Lyophilized (dry) Tirzepatide powder is stable at -20 degrees C for 12+ months and at 2-8 degrees C for several months before reconstitution. Once reconstituted with BAC water, the antimicrobial properties of the benzyl alcohol in BAC water extend the in-solution stability to approximately 28 days at 2-8 degrees C, versus 7-10 days if sterile water without preservative is used.
The primary degradation mechanisms for reconstituted Tirzepatide are thermal denaturation (heat above 25 degrees C) and repeated freeze-thaw cycles. Do not freeze reconstituted solution. UV light accelerates deamidation at asparagine residues, so amber or foil-wrapped vials are preferred for storage. A cloudy or particulate solution should be discarded.
For research and educational use only.
ASCEND · Blog · Calculator · Wiki